Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects

Full metadata record
DC Field Value Language
dc.contributor.authorKim, Mi-hyun-
dc.contributor.authorLee, Junghun-
dc.contributor.authorJung, Kyungjin-
dc.contributor.authorKim, Minjung-
dc.contributor.authorPark, Yun-Jin-
dc.contributor.authorAhn, Heechul-
dc.contributor.authorKwon, Young Hye-
dc.contributor.authorHah, Jung-Mi-
dc.date.accessioned2021-06-23T03:42:58Z-
dc.date.available2021-06-23T03:42:58Z-
dc.date.issued2013-04-
dc.identifier.issn0968-0896-
dc.identifier.issn1464-3391-
dc.identifier.urihttps://scholarworks.bwise.kr/erica/handle/2021.sw.erica/28398-
dc.description.abstract1-Heteroaryl-2-aryl-1H-benzimidazole derivatives were synthesized as inhibitors of c-Jun N-terminal kinases, JNK3. Their activities were evaluated through measurement of K-d using SPR, JNK3 kinase assay, and cell-viability of human neuroblastoma cells. Most tested compounds showed high affinity (10 mu M-46 nM) to JNK3. Among them, compound 16f exhibited potent activities (K-d = 46 nM). Especially, 16f was also found to present a potent cell protective effect (IC50 = 1.09 mu M) against toxicity induced by anisomycin, showing a possibility as protective therapeutics in neuronal cell apoptosis. (C) 2013 Elsevier Ltd. All rights reserved.-
dc.format.extent15-
dc.language영어-
dc.language.isoENG-
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD-
dc.titleSyntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects-
dc.typeArticle-
dc.publisher.location영국-
dc.identifier.doi10.1016/j.bmc.2013.02.021-
dc.identifier.scopusid2-s2.0-84875737494-
dc.identifier.wosid000316807800009-
dc.identifier.bibliographicCitationBIOORGANIC & MEDICINAL CHEMISTRY, v.21, no.8, pp 2271 - 2285-
dc.citation.titleBIOORGANIC & MEDICINAL CHEMISTRY-
dc.citation.volume21-
dc.citation.number8-
dc.citation.startPage2271-
dc.citation.endPage2285-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClasssci-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaBiochemistry & Molecular Biology-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalResearchAreaChemistry-
dc.relation.journalWebOfScienceCategoryBiochemistry & Molecular Biology-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalWebOfScienceCategoryChemistry, Organic-
dc.subject.keywordPlusNEURONAL APOPTOSIS-
dc.subject.keywordPlusINDUCTION-
dc.subject.keywordPlusPROTEIN-
dc.subject.keywordPlusDISEASE-
dc.subject.keywordPlusJNK3-
dc.subject.keywordAuthorBenzimidazole-
dc.subject.keywordAuthorNeuroprotective effect-
dc.subject.keywordAuthorNeurodegenerative disease-
dc.subject.keywordAuthorNeuroblastoma cell line-
dc.subject.keywordAuthorKinase inhibitor-
dc.subject.keywordAuthorJNK-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0968089613001454?via%3Dihub-
Files in This Item
Go to Link
Appears in
Collections
COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Hah, Jung Mi photo

Hah, Jung Mi
COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)
Read more

Altmetrics

Total Views & Downloads

BROWSE